- 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
- 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
黄葵胶囊联合缬沙坦治疗糖尿病肾病临床疗效观察
精品论文 参考文献
黄葵胶囊联合缬沙坦治疗糖尿病肾病临床疗效观察
黑龙江省望奎县中医院 黑龙江望奎 152100
摘要:目的:观察黄葵胶囊联合缬沙坦治疗糖尿病肾病临床疗效。方法:择取2014年1月-2016年1月我院收治的糖尿病肾病患者92例作为本次研究对象,按照患者的入院时间先后顺序随机将其等分为研究组和参照组,每组各包含46例患者,参照组患者采用缬沙坦药物治疗,研究组患者行黄葵胶囊联合缬沙坦药物治疗。结果:研究组患者的治疗有效率显著高于参照组患者,组间数据差异存在统计学意义(P<0.05)。结论:针对糖尿病肾病患者实施黄葵胶囊联合缬沙坦药物治疗,相较单纯实施缬沙坦药物治疗,能够显著改善和提升患者的临床治疗有效率,减低患者的24小时内尿液白蛋白排泄数量生理指标水平,优化患者在患病和接受期间的生理舒适程度和生存质量,延缓患者发生终末期肾衰竭临床结果的时间进程,应当引起广泛关注。
关键词:糖尿病肾病;黄葵胶囊;缬沙坦;临床观察
Huangkui capsule combined with valsartan in the treatment of Diabetic Nephropathy Clinical Observation
Zhao Yuping
(Wangkui County Hospital of traditional Chinese medicine,Heilongjiang,Wangkui 152100,Heilongjiang)
[Abstract]Objective:To observe the clinical effect of Huangkui capsule combined with valsartan in the treatment of diabetic nephropathy.Methods:selected January 2014 -2016 year in January in our hospital 92 cases of diabetic nephropathy patients as the research object,according to the patients were hospitalized were randomly divided into the study group and control group,each group included 46 patients,control group were treated with valsartan treatment,Huangkui capsule combined with valsartan in treatment of patients in the study group line.Results:the effective rate of treatment in the study group was significantly higher than that in the reference group,the difference was statistically significant(P lt; 0.05).Conclusion:the implementation of Huangkui capsule combined with valsartan in treatment of diabetic nephropathy patients,compared with the implementation of valsartan treatment,can significantly improve and enhance the efficiency of the clinical treatment of patients,reduce the risk of patients within 24 hours urine albumin excretion quantity of physiological indexes of water level,optimization in patient physiological during the illness and accept the comfort and quality of life,time the process of delaying the occurrence in patients with end-stage renal failure clinical results,should arouse extensive attentio
文档评论(0)